Status:
UNKNOWN
Efficacy of Myo-inositol in Preventing Gestational Diabetes in High-risk Pregnant Women
Lead Sponsor:
AGUNCO Obstetrics and Gynecology Centre
Conditions:
Gestational Diabetes
Eligibility:
FEMALE
20-45 years
Phase:
PHASE4
Brief Summary
The aim of this study is to evaluate the efficacy of myo-inositol in preventing gestational diabetes in high risk pregnant women.
Eligibility Criteria
Inclusion
- 60 women in their first trimester of pregnancy affected by one or more of the following risk factors:
- Glycemia levels \> 92 mg/dl
- BMI \> 30
- At least a parent or a brother (or sister)affected by diabetes
- Pre-existing pregnancy with gestational diabetes
Exclusion
- Pregnant women affected by pregestational diabetes
- Twin pregnancy
- Patients affected by pre-existing diseases in pregnancy (diabetes excluded)
- Patients affected by chronic disorders
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01511835
Last Update
January 19 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AGUNCO
Rome, Italy, 00155